Search

Your search keyword '"Battegay, M"' showing total 1,075 results

Search Constraints

Start Over You searched for: Author "Battegay, M" Remove constraint Author: "Battegay, M" Language english Remove constraint Language: english
1,075 results on '"Battegay, M"'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

3. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

4. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities.

6. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

8. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

10. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

11. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

12. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group

13. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

15. VIBRA trial - Village-based refill of ART following home-based same-day ART initiation: a cluster-randomized clinical trial

17. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

18. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

19. Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems

20. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

21. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

22. Hepatitis delta infection among persons living with HIV in Europe.

24. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

25. A highly virulent variant of HIV-1 circulating in the Netherlands

26. Children living with HIV in Europe: do migrants have worse treatment outcomes?

27. Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics

28. Observational cohort study of rilpivirine (RPV) utilization in Europe

29. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

30. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

31. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

33. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

34. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

37. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

39. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

40. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

41. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing

42. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

43. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

46. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

47. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Catalog

Books, media, physical & digital resources